Pulse lineResearch With Heart Logo

ARIC Publications

Filters: Keyword is Fibrin Fibrinogen Degradation Products  [Clear All Filters]
Thibord F, Song C, Pattee J, et al. FGL1 as a modulator of plasma D-dimer levels: Exome-wide marker analysis of plasma tPA, PAI-1, and D-dimer.. Vol. 19.; 2021. J Thromb Haemost 19(8).
Folsom AR, Alonso A, George KM, Roetker NS, Tang W. "Prospective study of plasma D-dimer and incident venous thromboembolism: The Atherosclerosis Risk in Communities (ARIC) Study." Thromb Res. 2015;136(4):781-5.
Gottesman RF, Cummiskey C, Chambless L, et al. "Hemostatic factors and subclinical brain infarction in a community-based sample: the ARIC study." Cerebrovasc Dis. 2009;28(6):589-94.
Lutsey PL, Folsom AR, Heckbert SR, Cushman M. "Peak thrombin generation and subsequent venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE) study." J Thromb Haemost. 2009;7(10):1639-48.
Cushman M, Folsom AR, Wang L, et al. "Fibrin fragment D-dimer and the risk of future venous thrombosis." Blood. 2003;101(4):1243-8.
Folsom AR, Aleksic N, Park E, Salomaa V, Juneja H, Wu KK. "Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study." Arterioscler Thromb Vasc Biol. 2001;21(4):611-7.
Salomaa V, Stinson V, Kark JD, Folsom AR, Davis CE, Wu KK. "Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study. Atherosclerosis Risk in Communities Study." Circulation. 1995;91(2):284-90.